Live Breaking News & Updates on Venture Partner At Longwood Fund

Stay updated with breaking news from Venture partner at longwood fund. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Engimmune Therapeutics Announces the Appointment of Dr Annalisa D'Andrea to its Board of Directors

/PRNewswire/ Engimmune Therapeutics AG ("Engimmune"), a Swiss biotech company developing novel T-cell receptor (TCR)-based therapeutics, is pleased to. ....

United States , Annalisa Dandrea , Kiniksa Pharmaceuticals , University Of Pennsylvania , Venture Partner At Longwood Fund , Bachelor Of Sciences , Wistar Institute , University Of Siena , Research Institute In Palo Alto , University Of Florence , Venture Partner , Longwood Fund , Chief Scientific Officer , Vice President , Global Head , Executive Director , Section Head , Ddiscovery Biology , Chiron Vaccines , Palo Alto , Annalisad Andrea , Engimmune Therapeutics ,